Home › Bronchiolitis Obliterans Syndrome › Massachusetts
Pag-aaral pangklinika para sa Bronchiolitis Obliterans Syndrome sa Massachusetts
14 pag-aaral para sa Bronchiolitis Obliterans Syndrome ang naghahanap ng mga kalahok sa mga site sa Massachusetts.
Mga Lungsod sa Massachusetts
Opisyal na teksto ng pag-aaral (English)
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07011810A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Nagre-recruitPhase 2
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07116031Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05996627A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Massachusetts Cancer Research Center, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05919511Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
- Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 2 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06991361Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 7 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07434869A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Massachusetts General Hospital, Boston
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06615050Direct to Patient Minimal Risk Biospecimen and Data Collection Research
- Joined Bio, Lexington
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 5, 2026 · NCT07128966Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT05236062A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2025 · NCT06462365Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.